Research Article

Nanoemulsion Based Hydrogel for Enhanced Transdermal Delivery of Ketoprofen

Table 6

Permeation parameters for various nanoemulgel formulations.

Formulation codeCADP (mg/cm2) FluxLag time (h)Drug retained (mg)

NG11.10 ± 0.040.057 ± 0.062.45 ± 0.211.40 ± 0.07
NG21.15 ± 0.060.058 ± 0.351.02 ± 0.161.35 ± 0.43
NG31.62 ± 0.020.072 ± 0.520.66 ± 0.260.88 ± 0.24
NG41.41 ± 0.070.064 ± 0.063.05 ± 0.231.09 ± 0.29
NG51.58 ± 0.120.066 ± 0.141.93 ± 0.180.92 ± 0.11
NG61.82 ± 0.230.074 ± 0.250.56 ± 0.640.68 ± 0.66
NG71.19 ± 0.300.057 ± 0.322.39 ± 0.181.31 ± 0.33
NG81.32 ± 0.280.059 ± 0.172.28 ± 0.111.18 ± 0.26
NG91.50 ± 0.060.063 ± 0.290.73 ± 0.281.00 ± 0.18
NS11.08 ± 0.09*0.041 ± 0.32*3.68 ± 0.38*1.42 ± 0.46*
NS21.11 ± 0.43*0.044 ± 0.18*3.43 ± 0.42*1.39 ± 0.19*
NS31.15 ± 0.42*0.045 ± 0.26*3.21 ± 0.42*1.35 ± 0.25*

Values are expressed as mean ± SD ().
CADP: cumulative amount of drug permeated.
; Student’s unpaired -test was used to compare NS batch (formulation prepared without cosurfactant) with NG6 (optimized formulation) for CADP, flux, and lag time.